MedPath

A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer

Phase 3
Completed
Conditions
Gastric Cancer
Interventions
Procedure: Roux-en Y reconstruction
Procedure: Billroth-I reconstruction
Registration Number
NCT01065688
Lead Sponsor
Wakayama Medical University
Brief Summary

The purpose of this study is to evaluate the quality of life (QOL) after Billroth-I reconstruction (B-I) following distal gastrectomy, compared with Roux-en Y reconstruction (R-Y) in patients with gastric cancer.

Detailed Description

The purpose of this study is to evaluate the quality of life (QOL) after Billroth-I reconstruction (B-I) following distal gastrectomy, compared with Roux-en Y reconstruction (R-Y) in patients with gastric cancer. There is no prospective randomized study of the two operative procedures focusing on postoperative QOL. The investigators conducted a prospective randomized trial on 120 patients who underwent distal gastrectomy comparing Billroth-I reconstruction and Roux-en Y reconstruction.

The primary endpoint was the postoperative QOL. The secondary endpoints were the incidence of postoperative complications, nutritional status, and the incidence of the remnant gastritis and the reflux esophagitis. Patients were recruited into this study before surgery, on the basis of whether distal gastrectomy was anticipated at Wakayama Medical University Hospital(WMUH) for gastric cancer, and appropriate informed consent was obtained. Exclusion criteria was 1) patients with severe complications which were possible to prolong hospital stay, 2) patients with history of other organ malignancies, 3) patients who were diagnosed inadequacy for this study by a physician, and 4) patients without an informed consent.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Histologically confirmed adenocarcinoma of stomach
  • Performance status: Eastern Cooperative Oncology Group (ECOG) 0-1
  • Tumor located in the antrum or the angle or the lower body of stomach
  • Appropriate informed consent was obtained.
Exclusion Criteria
  • Patients with severe complications which were possible to prolong hospital stay
  • Patients with history of other organ malignancies
  • Patients who were diagnosed inadequacy for this study by a physician
  • Patients without an informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Roux-en YRoux-en Y reconstructionRoux-en Y reconstruction after distal gastrectomy
Billroth-IBillroth-I reconstructionBillroth-I reconstruction after distal gastrectomy
Primary Outcome Measures
NameTimeMethod
the postoperative quality of life (QOL)3 years after operation
Secondary Outcome Measures
NameTimeMethod
the incidence of postoperative complications, nutritional status, and the incidence of the remnant gastritis and the reflux esophagitis1, 3 and 5 years after operation

Trial Locations

Locations (1)

Second Department of Surgery, Wakayama Medical University

🇯🇵

Wakayama, Japan

© Copyright 2025. All Rights Reserved by MedPath